Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Arno Therapeutics Inc (EM) ARNI

Healthcare Biotechnology
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration... see more

Current News (EXPM:ARNI)

Arno Therapeutics Announces Plans to Dissolve

Business Wire December 22, 2017

Arno Therapeutics Announces Plan to Deregister its Common Stock

Business Wire March 28, 2017

Arno Therapeutics Announces Update to Onapristone Prostate Cancer Development Program

Business Wire January 4, 2017

Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders

Business Wire December 21, 2016

Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update

Business Wire November 14, 2016

Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update

Business Wire August 22, 2016

Arno Completes $2.8 Million Private Placement

Business Wire August 16, 2016

Arno Therapeutics Reports First Quarter 2016 Financial and Business Update

GlobeNewswire May 16, 2016

Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA®

GlobeNewswire April 19, 2016
View More News ››

Opinion & Analysis (EXPM:ARNI)

What Andy Grove and Michael Milken have taught us about prostate cancer

The Life Sciences Report April 20, 2016
View More Opinion ››

Bullboard Posts (EXPM:ARNI)

Be the first to post on this bullboard.

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts